Today’s most significant insider transaction is a Form 4 filing by the president of Planet Labs PBC $PL, who reported a purchase of $997,113.
Millennium Management filed a 13G for AMC Entertainment $APE revealing an original stake of 5.30%.
Expert technical analysis of financial markets by JC Parets
by David
Today’s most significant insider transaction is a Form 4 filing by the president of Planet Labs PBC $PL, who reported a purchase of $997,113.
Millennium Management filed a 13G for AMC Entertainment $APE revealing an original stake of 5.30%.
by David
Today’s most significant insider transaction is a Form 4 filing by Global Infrastructure Investors III LLC.
The fund reported a purchase of $2.2 million in Clearway Energy $CWEN.
by David
Today’s most significant insider transaction report is a Form 4 filing by Cormorant Asset Management.
The firm revealed a purchase of $12 million in Biomea Fusion $BMEA.
by David
Today’s most significant insider transaction report is a Form 4 filing by Ares Management.
Ares revealed an additional purchase of roughly $2.9 million in Frontier Communications Parent $FYBR.
by David
The most significant insider transaction on today’s list comes in a Form 4 filed by RA Capital Management.
The hedge fund revealed a purchase of roughly $14.7 million of Dice Therapeutics $DICE, increasing its ownership stake to 16%.
by David
Today’s most significant insider transaction report is a Form 4 filing by Ares Management, which revealed a purchase of roughly $26.4 million in Frontier Communications Parent $FYBR.
The hedge fund now owns 36 million shares, which represents an ownership stake of 14.3%.
by David
Today’s most significant insider transaction report is another Form 4 filing by Warren Buffett’s Berkshire Hathaway $BRK.A for Occidental Petroleum $OXY.
On Monday, Buffett disclosed an additional purchase of OXY shares worth roughly $216 million.
by David
The most significant insider transaction on today’s list comes in a Form 4 filed by RA Capital Management.
The hedge fund revealed a purchase of roughly $13.4 million of Dice Therapeutics $DICE, increasing its ownership stake to 14.3%.